Registry of Monoclonal Gammopathies (RMG) - the monitored real-world database of the Czech Myeloma Group

被引：0

作者：

Maisnar, Vladimir ^{[1
,2
]}

Pour, Ludek ^{[3
]}

Spicka, Ivan ^{[4
,5
]}

Minarik, Jiri ^{[6
,7
]}

Pavlicek, Petr ^{[8
]}

Jelinek, Tomas ^{[9
]}

Jungova, Alexandra ^{[10
]}

Mistrik, Martin ^{[11
]}

Radocha, Jakub ^{[1
,2
]}

Heindorfer, Adriana ^{[12
]}

Sykora, Michal ^{[13
]}

Kessler, Petr ^{[14
]}

Stejskal, Lukas ^{[15
]}

Wrobel, Marek ^{[16
]}

Horinek, Daniel ^{[9
]}

Brozova, Lucie ^{[17
]}

Barinova, Magda ^{[17
]}

Hajek, Roman ^{[9
,18
]}

机构：

[1] Charles Univ Hosp, Hradec Kralove, Czech Republic

[2] Fac Med, Hradec Kralove, Czech Republic

[3] Masaryk Univ Hosp, Brno, Czech Republic

[4] Fac Med 1, Prague, Czech Republic

[5] Charles Univ Hosp, Prague, Czech Republic

[6] Palacky Univ, Univ Hosp, Olomouc, Czech Republic

[7] Palacky Univ, Fac Med & Dent, Olomouc, Czech Republic

[8] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic

[9] Univ Hosp, Ostrava, Czech Republic

[10] Univ Hosp, Plzen, Czech Republic

[11] Univ Hosp, Fac Med, Bratislava, Slovakia

[12] Hosp Liberec, Liberec, Czech Republic

[13] Hosp Ceske Budejovice, Ceske Budejovice, Czech Republic

[14] Hosp Pelhrimov, Pelhrimov, Czech Republic

[15] Hosp Opava, Opava, Czech Republic

[16] Hosp Novy Jicin, Novy Jicin, Czech Republic

[17] Inst Biostat & Anal Ltd, Brno, Czech Republic

[18] Fac Med, Ostrava, Czech Republic

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

monoclonal gammopathies; real-world; registry;

D O I：

10.1016/j.clml.2019.09.533

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SP-207

引用

页码：E324 / E325

页数：2

共 50 条

[31] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
Gliklich, Richard E.
Leavy, Michelle B.
[J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
[32] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
Richard E. Gliklich
Michelle B. Leavy
[J]. Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
[33] Real-World Registry on the Pharmacotherapy of Multiple Myeloma and Associated Renal and Pulmonary Impairments in the Greater Gulf Region: Protocol for a Retrospective Real-World Data Study
Nourallah, Abdulnaser
Alshehri, Abdulrahman
Alhejazi, Ayman
Usman, Binyam
Elgohary, Ghada
Malhan, Hafiz
Motabi, Ibraheem
Al Farsi, Khalil
Alshuaibi, Mohammed
Siddiqui, Mustaqeem
Ghonema, Rasha
Taha, Ruba Yasin
Abouzeid, Tarek
Ahmed, Wesam
Diab, Mohanad
Alhuraiji, Ahmad
Rabea, Magdy
Chouikrat, Mohamed Zahir
[J]. JMIR RESEARCH PROTOCOLS, 2024, 13
[34] Descriptive analysis of multiple myeloma patients in a real-world setting from the Finnish Hematology Registry
Tskhvarashvili, Giorgi
Hakkarainen, Katja M.
Klement, Riho
Vattulainen, Pia
Miettinen, Tatu
Torvinen, Saku
Lievonen, Juha
[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 17 (02):
[35] Sex differences in efficacy and safety of PCSK9 monoclonal antibodies: A real-world registry
Galema-Boers, Annette M. H.
Mulder, Janneke W. C. M.
Steward, Kim
van Lennep, Jeanine E. Roeters
[J]. ATHEROSCLEROSIS, 2023, 384
[36] Validation of the second revision of the international staging system in a real-world myeloma population: a myeloma and related diseases registry study
Tan, Joanne
Wellard, Cameron
Moore, Elizabeth
Spencer, Andrew
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S124 - S124
[37] Impact of Daratumumab-Containing Regimens in Outcomes of Subsequent Treatments of Relapsed Multiple Myeloma in Real-World Practice from the Canadian Myeloma Research Group Database
Leblanc, Richard
Venner, Christopher P.
Masih-Khan, Esther
Kardjadj, Moustafa
Chu, Michael P.
Jimenez-Zepeda, Victor H.
McCurdy, Arleigh
Song, Kevin
Sebag, Michael
Louzada, Martha L.
Mian, Hira S.
White, Darrell J.
Stakiw, Julie
Kotb, Rami
Reiman, Anthony
Aslam, Muhammad
Kaedbey, Rayan
Gul, Engin
Reece, Donna E.
[J]. BLOOD, 2022, 140 : 7192 - 7194
[38] Real-world experience with Cladribine in the MSBase Registry
Butzkueven, H.
Spelman, T.
Patti, F.
Eichau, S.
Grand'Maison, F.
Kalincik, T.
Hodgkinson, S.
Skibina, O.
Butler, E.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 326 - 327
[39] Real-world experience with Ocrelizumab in the MSBase Registry
Butzkueven, H.
Spelman, T.
Patti, F.
Ozakbas, S.
Eichau, S.
Alroughani, R.
Terzi, M.
Boz, C.
Grand'Maison, F.
Grammond, P.
Kalincik, T.
Van Pesch, V.
Lechner-Scott, J.
Barnett, M.
Kuhle, J.
Hodgkinson, S.
Skibina, O.
Soysal, A.
Butler, E.
Slee, M.
Prevost, J.
Laureys, G.
Macdonell, R.
van Beek, J.
Craveiro, L.
Wormser, D.
Muros-Le Rouzic, E.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 539 - 540
[40] Real-world experience with ocrelizumab in the msbase registry
Butzkueven, H.
Spelman, T.
Ozakbas, S.
Kalincik, T.
Boz, C.
Buzzard, K.
Skibina, O.
Alroughani, R.
Karabudak, R.
Van der Walt, A.
Lechner-Scott, J.
Hodgkinson, S.
Laureys, G.
Van Hijfte, L.
Terzi, M.
Butler, E.
Macdonell, R.
Patti, F.
Van Pesch, V.
Slee, M.
Barnett, M.
Grammond, P.
Prevost, J.
Grand-Maison, F.
Taylor, B.
Kermode, A.
Mccombe, P.
Duquette, P.
Prat, A.
Girard, M.
Eichau Madueno, S.
Izquierdo, G.
Soysal, A.
Sanchez-Menoyo, J. L.
Sotoca, J.
Muros-Le Rouzic, E.
Dirks, P.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 550 - 551

← 1 2 3 4 5 →